Nuclear clusterin accumulation during heat shock response: Implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells

2006 ◽  
Vol 207 (1) ◽  
pp. 208-219 ◽  
Author(s):  
Alessandro E. Caccamo ◽  
Silvia Desenzani ◽  
Lucia Belloni ◽  
Angelo F. Borghetti ◽  
Saverio Bettuzzi
2016 ◽  
Vol 97 (1) ◽  
pp. 112-117 ◽  
Author(s):  
Martin Weiss ◽  
Hannes Ahrend ◽  
Hannah Grossebrummel ◽  
Patrick Ziegler ◽  
Lars-Ove Brandenburg ◽  
...  

2009 ◽  
Vol 124 (7) ◽  
pp. 1675-1684 ◽  
Author(s):  
Vinita Singh-Gupta ◽  
Hao Zhang ◽  
Sanjeev Banerjee ◽  
Dejuan Kong ◽  
Julian J. Raffoul ◽  
...  

Proceedings ◽  
2020 ◽  
Vol 40 (1) ◽  
pp. 42
Author(s):  
Kashani ◽  
Kilbas ◽  
Yerlikaya ◽  
Gurkan ◽  
Arisan

Prostate cancer is the second common cause of death among men worldwide. In the treatment of prostate cancer, conventional chemotherapeutics are commonly used. The plant alkaloid Paclitaxel and platinum-based cisplatin are the most common chemotherapy drugs. The transcription factor p53 has a potential target in the regulation of cell response to DNA damage of prostate cancer. Although the effectiveness of these drugs on prostate cancer cell progression had been proved, the mechanistic action of these drugs on the progression of the disease is not detailed explained. In this study, we aim to examine the function of p53 overexpression in prostate cancer cell survival. Therefore, we treated wild type (wt) and p53 overexpressed PC3 (p53+) prostate cancer cells with cisplatin or paclitaxel. According to the MTT Cell Viability assay, cisplatin (12.5–25–50 µM) was found to be more effective decreasing PC3 and PC3 p53+ cell viability in a dose-dependent manner compared to paclitaxel (12.5–25–50 nM). Colony formation assay showed that treatment of cells with cisplatin or paclitaxel caused the loss of colony forming ability of PC3 and PC3 p53+ cells. In addition, the critical apoptotic markers Caspase-3 and Caspase-9 expressions were altered with cisplatin or paclitaxel treated PC3 wt and p53+ cells.


2017 ◽  
Vol 108 (9) ◽  
pp. 1820-1827 ◽  
Author(s):  
Kazuaki Kita ◽  
Masayuki Shiota ◽  
Masako Tanaka ◽  
Asuka Otsuka ◽  
Masaki Matsumoto ◽  
...  

2015 ◽  
Vol 88 (1) ◽  
pp. 121-130 ◽  
Author(s):  
Weiya Liu ◽  
George A. Vielhauer ◽  
Jeffrey M. Holzbeierlein ◽  
Huiping Zhao ◽  
Suman Ghosh ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document